Experienced in Undifferentiated Pleomorphic Sarcoma

Dr. Rodney Jamil

Hematology
HackenSack Meridian health
Riverview Medical Center
1 Riverview Plaza, 
Red Bank, NJ 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Undifferentiated Pleomorphic Sarcoma
HackenSack Meridian health
Riverview Medical Center
1 Riverview Plaza, 
Red Bank, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Rodney Jamil is a Hematologist in Red Bank, New Jersey. Dr. Jamil is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and ALK-Positive Non-Small Cell Lung Cancer.

His clinical research consists of participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Georgetown University School Of Medicine
Residency
Tufts-New England Medical Center
Specialties
Hematology
Licenses
Internal Medicine in MA
Board Certifications
American Board Of Internal Medicine
Medical Oncology
Fellowships
Beth Israel Deaconess Medical Center-Main Campus
Hospital Affiliations
Penn Highlands Mon Valley
Penn Highlands Connellsville
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthKeepers
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Riverview Medical Center
1 Riverview Plaza, Red Bank, NJ 7701.

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Recruiting
Publish Date: July 03, 2024
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: December 17, 2025
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-Map Sub-Study)
A Phase III Randomized Study of Nivolumab Plus Ipilimumab Versus Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-Map Sub-Study)
Enrollment Status: Active_not_recruiting
Publish Date: May 21, 2025
Intervention Type: Other, Biological
Study Drugs: Ipilimumab, Nivolumab
Study Phase: Phase 3
A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-Map)
A Biomarker-Driven Master Protocol for Previously Treated Squamous Cell Lung Cancer (Lung-Map)
Enrollment Status: Completed
Publish Date: June 01, 2023
Intervention Type: Biological, Drug, Other
A Phase II Study of Talazoparib (BMN 673) in Patients With Homologous Recombination Repair Deficiency Positive Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)
A Phase II Study of Talazoparib (BMN 673) in Patients With Homologous Recombination Repair Deficiency Positive Stage IV Squamous Cell Lung Cancer (Lung-Map Sub-Study)
Enrollment Status: Completed
Publish Date: June 23, 2021
Intervention Type: Other, Drug
Study Drug: Talazoparib
Study Phase: Phase 2
View 5 Less Clinical Trials
Similar Doctors
Distinguished in Undifferentiated Pleomorphic Sarcoma
Dr. Lee Hartner
Hematology | Oncology
Distinguished in Undifferentiated Pleomorphic Sarcoma
Dr. Lee Hartner
Hematology | Oncology

Abramson Cancer Center Radnor

145 King Of Prussia Road, Floor 2, Suite 200 North, 
Radnor, PA 
 (241.2 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lee Hartner is a Hematologist and an Oncologist in Radnor, Pennsylvania. Dr. Hartner is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Retroperitoneal Liposarcoma, Liposarcoma, Gastrostomy, and Endoscopy. Dr. Hartner is currently accepting new patients.

Advanced in Undifferentiated Pleomorphic Sarcoma
Dr. Ingrid Kohut
Hematology | Oncology
Advanced in Undifferentiated Pleomorphic Sarcoma
Dr. Ingrid Kohut
Hematology | Oncology

Abramson Cancer Center Radnor

145 King Of Prussia Road, Floor 2, Suite 200 North, 
Radnor, PA 
 (241.2 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ingrid Kohut is a Hematologist and an Oncologist in Radnor, Pennsylvania. Dr. Kohut is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Sickle Cell Disease, Iron Deficiency Anemia, Bone Tumor, Rhabdoid Tumor, and Endoscopy. Dr. Kohut is currently accepting new patients.

Advanced in Undifferentiated Pleomorphic Sarcoma
Dr. Patricia A. Ford
Hematology | Oncology
Advanced in Undifferentiated Pleomorphic Sarcoma
Dr. Patricia A. Ford
Hematology | Oncology

Penn Hematology/Oncology Pennsylvania Hospital

719 Manning St, Farm Journal Building, 2nd Floor, 
Philadelphia, PA 
 (252.9 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Patricia Ford is a Hematologist and an Oncologist in Philadelphia, Pennsylvania. Dr. Ford is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Pleomorphic Sarcoma. Her top areas of expertise are Angiosarcoma, Sickle Cell Disease, Paget Disease of the Breast, Bone Marrow Transplant, and Endoscopy. Dr. Ford is currently accepting new patients.

VIEW MORE UNDIFFERENTIATED PLEOMORPHIC SARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jamil's expertise for a condition
ConditionClose
      • Advanced
      • ALK-Positive Non-Small Cell Lung Cancer
        Dr. Jamil is
        Advanced
        . Learn about ALK-Positive Non-Small Cell Lung Cancer.
        See more ALK-Positive Non-Small Cell Lung Cancer experts
      • Breast Cancer
        Dr. Jamil is
        Advanced
        . Learn about Breast Cancer.
        See more Breast Cancer experts
      • Childhood Iron Deficiency Anemia
        Dr. Jamil is
        Advanced
        . Learn about Childhood Iron Deficiency Anemia.
        See more Childhood Iron Deficiency Anemia experts
      • Colorectal Cancer
        Dr. Jamil is
        Advanced
        . Learn about Colorectal Cancer.
        See more Colorectal Cancer experts
      • EGFR Positive Lung Cancer
        Dr. Jamil is
        Advanced
        . Learn about EGFR Positive Lung Cancer.
        See more EGFR Positive Lung Cancer experts
      • Familial Colorectal Cancer
        Dr. Jamil is
        Advanced
        . Learn about Familial Colorectal Cancer.
        See more Familial Colorectal Cancer experts
      View All 19 Advanced Conditions
      • Experienced
      • Acute Mountain Sickness
        Dr. Jamil is
        Experienced
        . Learn about Acute Mountain Sickness.
        See more Acute Mountain Sickness experts
      • Adrenal Cancer
        Dr. Jamil is
        Experienced
        . Learn about Adrenal Cancer.
        See more Adrenal Cancer experts
      • Adult Immune Thrombocytopenia
        Dr. Jamil is
        Experienced
        . Learn about Adult Immune Thrombocytopenia.
        See more Adult Immune Thrombocytopenia experts
      • Adult Soft Tissue Sarcoma
        Dr. Jamil is
        Experienced
        . Learn about Adult Soft Tissue Sarcoma.
        See more Adult Soft Tissue Sarcoma experts
      • Agranulocytosis
        Dr. Jamil is
        Experienced
        . Learn about Agranulocytosis.
        See more Agranulocytosis experts
      • Anaplastic Thyroid Cancer
        Dr. Jamil is
        Experienced
        . Learn about Anaplastic Thyroid Cancer.
        See more Anaplastic Thyroid Cancer experts
      View All 135 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.